Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

916
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
916
Neural Regulation01:37

Neural Regulation

43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Brainstem01:19

Brainstem

5.5K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of sociodemographic and behavioral factors with frailty transition patterns: a multi-state Markov analysis of the China Health and Retirement Longitudinal Study (CHARLS).

Archives of public health = Archives belges de sante publique·2026
Same author

Heritability of Triglyceride-Glucose Index in Middle-Aged and Older Chinese Twins: Overall Estimates and Sex-Stratified Analysis.

Twin research and human genetics : the official journal of the International Society for Twin Studies·2026
Same author

Sex differences and alcohol modulation in the heritability of MASLD: a twin study of the 2023 definition.

Human genetics·2026
Same author

Dietary folate intake and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.

Nutrition & metabolism·2026
Same author

Epigenomewide Association Study of Monozygotic Twins Reveals That Serum Uric Acid Influences DNA Methylation.

Twin research and human genetics : the official journal of the International Society for Twin Studies·2026
Same author

Rationale and design of a multicenter, prospective, diagnostic clinical study: A study protocol for evaluating the diagnostic validation of deep learning-based noninvasive CT-FFR for in-stent restenosis.

PloS one·2026

Related Experiment Video

Updated: Jan 5, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

996

Iron Concentration Does Not Differ in Blood but Tends to Decrease in Cerebrospinal Fluid in Parkinson's Disease.

Xiaoli Shen1,2, Huazhen Yang3, Dongfeng Zhang2

  • 1Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders and State Key Disciplines: Physiology, Qingdao University, Qingdao, China.

Frontiers in Neuroscience
|October 17, 2019
PubMed
Summary
This summary is machine-generated.

Iron levels in cerebrospinal fluid (CSF) are lower in Parkinson

Keywords:
Parkinson’s diseasebloodcerebrospinal fluidironmeta-analysis

More Related Videos

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.1K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.0K

Related Experiment Videos

Last Updated: Jan 5, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

996
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.1K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.0K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Clinical Neurology

Background:

  • Iron accumulation in the substantia nigra is a known factor in Parkinson's disease (PD).
  • Previous studies reported inconsistent findings regarding iron levels in blood and cerebrospinal fluid (CSF) of PD patients.
  • Understanding iron dysregulation is crucial for PD pathogenesis and potential therapeutic strategies.

Purpose of the Study:

  • To investigate alterations in blood and CSF iron levels in Parkinson's disease patients.
  • To conduct a case-control study and a meta-analysis to clarify iron level changes in PD.
  • To determine if iron dysregulation is specific to the central nervous system or also present peripherally.

Main Methods:

  • A case-control study involving 43 PD patients and 33 controls, with CSF analysis from 15 normal and 12 PD patients.
  • Iron levels quantified using inductively coupled atomic emission spectrometry.
  • A meta-analysis of 22 studies (3607 participants) published between 1980-2018, using a random effects model to estimate associations.

Main Results:

  • No significant difference in serum iron levels between PD patients and controls (p=0.850).
  • Lower ferritin levels observed in PD patients compared to controls (p=0.014).
  • Significantly lower CSF iron levels in PD patients compared to controls (p=0.021), with a moderate effect size.

Conclusions:

  • Iron homeostasis appears to be disturbed within the cerebrospinal fluid (CSF) in Parkinson's disease.
  • Peripheral blood iron levels do not show significant alterations in PD patients.
  • Findings suggest a potential role for CSF iron dysregulation in PD pathogenesis.